Literature DB >> 16716261

Purification and identification of a BMP-like factor from bovine serum.

Kunihiko Kodaira1, Mana Imada, Masaaki Goto, Akihiro Tomoyasu, Toru Fukuda, Ryutaro Kamijo, Tatsuo Suda, Kanji Higashio, Takenobu Katagiri.   

Abstract

Myogenic differentiation is suppressed in vitro by unknown factors present in fetal bovine serum (FBS). We found that specific inhibitors of bone morphogenetic proteins (BMPs) stimulated myogenic differentiation even in the presence of 20% FBS, which in turn activated specific BMP signaling. Moreover, these specific BMP inhibitors blocked maturation of osteoblastic cells induced by FBS, indicating that BMP-like factor(s) in serum regulate both myogenic and osteoblastic differentiation. The factor identified had an apparent molecular weight (Mw) of over 100kDa on a Superdex 200 column for molecular sieving HPLC, but an apparent Mw of 33kDa on SDS-PAGE under non-reducing conditions. Analysis of a purified preparation from FBS (5L) by liquid chromatography-tandem mass spectrometry revealed the presence of an amino acid sequence conserved between mature human and murine BMP-4. This is the first study to show that BMP-4 is present in FBS as a large complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716261     DOI: 10.1016/j.bbrc.2006.05.045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Bone morphogenetic protein 4 mediates human embryonic germ cell derivation.

Authors:  Marc Hiller; Cyndi Liu; Paul D Blumenthal; John D Gearhart; Candace L Kerr
Journal:  Stem Cells Dev       Date:  2010-10-21       Impact factor: 3.272

2.  Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.

Authors:  Shoichiro Kokabu; Satoshi Ohte; Hiroki Sasanuma; Masashi Shin; Katsumi Yoneyama; Eiko Murata; Kazuhiro Kanomata; Junya Nojima; Yusuke Ono; Tetsuya Yoda; Toru Fukuda; Takenobu Katagiri
Journal:  Mol Endocrinol       Date:  2011-01-14

3.  Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins.

Authors:  Junya Nojima; Kazuhiro Kanomata; Yumi Takada; Toru Fukuda; Shoichiro Kokabu; Satoshi Ohte; Takatora Takada; Tohru Tsukui; Takamasa S Yamamoto; Hiroki Sasanuma; Katsumi Yoneyama; Naoto Ueno; Yasushi Okazaki; Ryutaro Kamijo; Tetsuya Yoda; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.

Authors:  Marie Bidart; Nicolas Ricard; Sandrine Levet; Michel Samson; Christine Mallet; Laurent David; Mariela Subileau; Emmanuelle Tillet; Jean-Jacques Feige; Sabine Bailly
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

5.  Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.

Authors:  Ryuichiro Yamamoto; Masaki Matsushita; Hiroshi Kitoh; Akio Masuda; Mikako Ito; Takenobu Katagiri; Tatsushi Kawai; Naoki Ishiguro; Kinji Ohno
Journal:  J Bone Miner Metab       Date:  2012-08-24       Impact factor: 2.626

6.  Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage.

Authors:  K L Grinnell; J R Bickenbach
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

7.  Presenilin-1 acts via Id1 to regulate the function of muscle satellite cells in a gamma-secretase-independent manner.

Authors:  Yusuke Ono; Viola F Gnocchi; Peter S Zammit; Ryoichi Nagatomi
Journal:  J Cell Sci       Date:  2009-11-17       Impact factor: 5.285

8.  Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.

Authors:  Toru Fukuda; Masakazu Kohda; Kazuhiro Kanomata; Junya Nojima; Atsushi Nakamura; Jyunji Kamizono; Yasuo Noguchi; Kiyofumi Iwakiri; Takeo Kondo; Junichi Kurose; Ken-ichi Endo; Takeshi Awakura; Junichi Fukushi; Yasuharu Nakashima; Tomohiro Chiyonobu; Akira Kawara; Yoshihiro Nishida; Ikuo Wada; Masumi Akita; Tetsuo Komori; Konosuke Nakayama; Akira Nanba; Yuichi Maruki; Tetsuya Yoda; Hiroshi Tomoda; Paul B Yu; Eileen M Shore; Frederick S Kaplan; Kohei Miyazono; Masaru Matsuoka; Kenji Ikebuchi; Akira Ohtake; Hiromi Oda; Eijiro Jimi; Ichiro Owan; Yasushi Okazaki; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

9.  Targeting of bone morphogenetic protein growth factor complexes to fibrillin.

Authors:  Gerhard Sengle; Noe L Charbonneau; Robert N Ono; Takako Sasaki; Jennifer Alvarez; Douglas R Keene; Hans Peter Bächinger; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

10.  Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation.

Authors:  Shinya Obayashi; Hiroko Tabunoki; Seung U Kim; Jun-ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2009-01-07       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.